IP Library › Granted Patent US 11,123,318
Granted Patent B2
US 11,123,318 · App. 16/526,365 · Granted Sep 21, 2021

Substantially sodium free diclofenac potassium oral solutions

Inventors: Giorgio Reiner (Como, IT); Alberto Reiner (Como, IT); Paola Maffei (Bologna, IT)
Assignee: APR Applied Pharma Research S.A.
A61K31/196A61K9/08A61P29/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,123,318
App. No.
16/526,365
Granted
Sep 21, 2021
Kind
B2
Abstract

Provided are orally formulations of diclofenac potassium with improved stability in response to cold conditions, and excellent taste and palatability.

Claims (34)

1. A method of making a liquid composition of diclofenac potassium comprising:

a) preparing a first mixture comprising diclofenac potassium and ethanol;

b) mixing water and glycerol in said first mixture until a second mixture is obtained;

c) preparing a third mixture comprising water, potassium hydrogen carbonate, and sucralose;

d) mixing the third mixture and second mixture and adding water to make a final mixture;

wherein:

i) said liquid composition comprises diclofenac potassium salt in an amount from 3.5 to 20% (w/v) with respect to the volume of the composition;

ii) said liquid composition comprises potassium bicarbonate in an amount from 2.0 to 10.0% (w/v) with respect to the volume of the composition; and

iii) sodium is absent or present in an amount of up to 0.05% by weight with respect to the volume of the composition.

2. The method of claim 1 , wherein said diclofenac potassium salt is present in said composition in an amount of about 5% (w/v) with respect to the volume of the composition.

3. The method of claim 1 , or 2 , wherein said potassium bicarbonate is present in said composition in an amount from 2.0 to 5.0% (w/v) with respect to the volume of the composition.

4. The method of claim 1 , 2 , or 3 , wherein said composition has a density of from 1.0 to 1.1 g/ml.

5. The method of claim 1 , 2 , 3 or 4 , wherein said composition further comprises at least one sweetener substantially free of sodium ions.

6. The method of claim 1 , 2 , 3 , 4 , or 5 , wherein said composition further comprises from 0.3 to 2.0% (w/v) of a sweetener substantially free of sodium ions with respect to the volume of the composition.

7. The method of claim 1 , 2 , 3 , 4 , 5 , or 6 , wherein said composition further comprises a sweetener selected from the group consisting of sucralose, aspartame, thaumatin, isomalt, maltitol, lactitol, and xylitol.

8. The method of claim 1 , 2 , 3 , 4 , 5 , 6 , or 7 , wherein said glycerol is present in an amount from 10 to 50% (w/v) with respect to the volume of the composition.

9. The method of claim 1 , wherein said composition comprises:

a) about 5 weight parts diclofenac potassium,

b) about 30 weight parts ethyl alcohol,

c) about 20 weight parts glycerol,

d) about 2.5 weight parts potassium hydrogen carbonate,

e) about 0.5 weight parts sucralose,

f) about 42.9 weight parts water; and

g) optionally about 0.00336 weight parts E129 and about 0.000168 weight parts E133.

10. The method of claim 9 wherein said composition has a density of between 1.0 and 1.1 g/ml.

11. The method of claim 1 , 2 , 3 , 5 , 6 , 7 , 8 , 8 , or 10 , further comprising dispensing said composition to a vial containing from about 10 to about 100 mg of said diclofenac potassium.

12. The method of claim 1 , further comprising mixing dye Allura Red (E129) and Brilliant Blue (E133) in step (c) to make said third mixture.

13. The method of claim 1 , wherein:

a) step (a) is carried out with 120 weight parts ethanol per 20 weight parts potassium diclofenac;

b) step (b) is carried out with 80 weight parts glycerol and 120 weight parts water per 20 weight parts potassium diclofenac;

c) step (c) is carried out with 56.6 weight parts water, 10 weight parts potassium hydrogen carbonate, and 2 weight parts sucralose per 20 weight parts diclofenac potassium; and

d) water is added in step (d) until a 5% w/v solution is obtained based on the weight of potassium diclofenac at a density of approximately 1.030 g/mL.

14. The method of claim 1 , further comprising mixing 0.01344 weight parts dye Allura Red (E129) and 0.00067 weight parts Brilliant Blue (E133) in step (c) to make said third mixture.

15. The method of claim 1 , wherein said potassium bicarbonate is present in said composition in an amount of from 2.5 to 3.0% (w/v) with respect to the volume of the composition.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2026
From: APR APPLIED PHARMA RESEARCH SA
To: ALKEMIRA SA
Reel/Frame 076110/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2020
From: REINER, GIORGIO; REINER, ALBERTO
To: APR APPLIED PHARMA RESEARCH S.A.
Reel/Frame 052931/0522 →
Priority Claims (1)
IT 102017000009711 · Jan 30, 2017 · national
Continuity (2)
Continuation PCTIB2018050505 · Jan 27, 2018
Related Publication 20200093772A1 · Mar 26, 2020